Advertisement

Topics

Latest "Chiral Technologies" News Stories

17:06 EST 13th November 2018 | BioPortfolio

Here are the most relevant search results for "Chiral Technologies" found in our extensive news archives from over 250 global news sources.

More Information about Chiral Technologies on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Chiral Technologies for you to read. Along with our medical data and news we also list Chiral Technologies Clinical Trials, which are updated daily. BioPortfolio also has a large database of Chiral Technologies Companies for you to search.

Showing "Chiral Technologies" News Articles 1–25 of 4,800+

Relevant

Chiral Separations With Magnets. No, For Real.

Now here is something I didn’t expect: what may well be a completely new way to separate enantiomers, not based in any way on shape recognition versus another chiral substance. [Quick background for those not in the field: a great many three-dimensional molecules can exist in right-handed and left-handed mirror-image forms (enantiomers), exactly like pairs


Chemists invent new method for remote chiral induction

Chemists at Scripps Research have addressed one of the most formidable challenges in synthetic chemistry by inventing a method for "enantioselective remote meta-CH activation," which enables the making of chiral molecules that were previously difficult or impossible to synthesize.

Missouri S&T Chemist Rolls the Dice to Better Identify Chiral Molecules in Drugs

“High risk, high reward” is the kind of discovery Dr. Garry Grubbs seeks with a new experiment designed to rapidly identify the atomic structure of chiral molecules widely used in pharmaceutical drugs


Global Chiral Chemicals Market 2018-2022: FDA has Approved the Use of Chiral Chemicals for the ...

ResearchAndMarkets.comLaura Wood, Senior Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900Related Topics: Pharmaceutical Intermediates Read more...

Chiral heterocycles

Topological quantum properties of chiral crystals

Spin control in reduced-dimensional chiral perovskites

Enantioselective remote meta-C–H arylation and alkylation via a chiral transient mediator

Site-selective photoinduced cleavage and profiling of DNA by chiral semiconductor nanoparticles

Pentamethylcyclopentadienyl rhodium(III)–chiral disulfonate hybrid catalysis for enantioselective C–H bond functionalization

Author Correction: Evidence for trivial Berry phase and absence of chiral anomaly in semimetal NbP

Collective antiskyrmion-mediated phase transition and defect-induced melting in chiral magnetic films

Global Chiral Chemicals Market 2018-2022 | 10% CAGR Projection Over the Next Four Years | Technavio

The global chiral chemicals market is expected to post a CAGR of close to 10% during the period 2018-2022, according to the latest market research report by Technavio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180808005527/en/

Chemists achieve major milestone of synthesis: Remote chiral induction

(Scripps Research Institute) 'This new method should allow us to explore a large 'chemical space' that had been essentially off-limits.'

A Simple Route to Highly Chiral Materials

NewsChirality is at the heart of chemical research and much technology.

BioStem Technologies filing four pre-investigational new drug applications by end of year

BioStem Technologies, Inc. is a global life sciences corporation, providing innovative technologies with a concentration in Pharmaceuticals and Regenerative Medicine.

Incessant Technologies est citée comme une entreprise très performante par un cabinet de ...

HYDERABAD, Inde, October 4, 2018 /PRNewswire/ -- Incessant Technologies, une entreprise de NIIT Technologies, a été parmi les sociétés que Forrester a choisi d'inviter à Read more...

Probably Relevant

Delphi Technologies reports third quarter 2018 financial results

LONDON, Nov. 7, 2018 /PRNewswire/ -- Delphi Technologies PLC (NYSE: DLPH) ("Delphi Technologies" or the "Company"), a global leader in vehicle propulsion, today reported third Read more...

Syncom BV Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24092018] Prices from USD $250

SummarySyncom BV Syncom is a provider of custom synthesis solutions. The company's activities include synthesis of key building blocks, route scouting services, process research activities and medicinal chemistry services. Its service portfolio includes contract research services, chiral technology services, medicinal chemistry services and analytical services. The company also offers customized s...

Syncom BV Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 20062018] Prices from USD $250

SummarySyncom BV Syncom is a provider of custom synthesis solutions. The company's activities include synthesis of key building blocks, route scouting services, process research activities and medicinal chemistry services. Its service portfolio includes contract research services, chiral technology services, medicinal chemistry services and analytical services. The company also offers customized s...

#jobs #lifescience OMass Technologies: Protein Biochemist

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: OMass Technologies: Protein Biochemist . Comptitive: OMass Technologies: OMass Technologies is inviting applications for several biochemist positions, focussed on the expression and purification of GPCRs for drug discovery. Oxford, Oxfordshire … Continue reading →...

Living Cell Technologies: New Technologies and Clinical Trials

In this episode of PharmaTelevision News Review, Fintan Walton talks with Dr Paul Tan, CEO of Living Cell Technologies. Filmed at AusBiotech 2009, they discuss: • The company’s origins and aims • Pig islet transplantation to combat diabetes • Results of Russian and New Zealand clinical trials • Living Cell Technologies’ issues with clinical trials in Australia • The company’s searc...

#jobs #lifescience OMass Technologies: Mass Spectrometry Scientist

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: OMass Technologies: Mass Spectrometry Scientist . Comptitive: OMass Technologies: OMass Technologies is inviting applications for several mass spec scientist positions, focussed on the investigation of GPCRs for drug discovery. Oxford, Oxfordshire (GB) from Job … C...

These Are The Disruptive Technologies That Will Affect Your Industry

These are the technologies that are coming to disrupt your industries. Some don't exist yet but all are plausible. You should be worried...and inspired.

Double Helix Technologies teams-up with Agilent Technologies to offer the SureVector Cloning System

Venice, Italy, 10th October 2017 / Sciad Newswire / Double Helix Technologies (Doulix) announced today a collaboration with Agilent Technologies Inc. (NYSE: A) to promote Agilent's SureVector next-generation cloning kits through Doulix’s web platform. Through this partnership, synthetic biologists will be able to choose among SureVector’s standard DNA parts to design custom plasmids using ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks